PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 162 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $478,505 | -25.5% | 181,941 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $642,252 | +8.8% | 181,941 | -4.8% | 0.00% | +100.0% |
| Q1 2023 | $590,385 | -60.2% | 191,063 | -45.5% | 0.00% | -75.0% |
| Q4 2022 | $1,481,693 | +76.0% | 350,282 | -1.4% | 0.00% | +100.0% |
| Q3 2022 | $842,000 | -15.9% | 355,368 | +1.2% | 0.00% | -33.3% |
| Q2 2022 | $1,001,000 | +2.0% | 351,117 | +3.1% | 0.00% | +50.0% |
| Q1 2022 | $981,000 | +5.0% | 340,459 | +10.9% | 0.00% | 0.0% |
| Q4 2021 | $934,000 | -55.2% | 307,117 | +3.3% | 0.00% | -50.0% |
| Q3 2021 | $2,083,000 | -16.0% | 297,203 | +10.0% | 0.00% | -20.0% |
| Q2 2021 | $2,480,000 | -5.8% | 270,127 | -0.2% | 0.01% | 0.0% |
| Q1 2021 | $2,632,000 | -15.7% | 270,736 | -11.0% | 0.01% | -16.7% |
| Q4 2020 | $3,122,000 | -29.5% | 304,343 | -30.7% | 0.01% | -40.0% |
| Q3 2020 | $4,428,000 | -8.9% | 438,877 | -5.9% | 0.01% | -16.7% |
| Q2 2020 | $4,863,000 | -42.9% | 466,266 | -53.8% | 0.01% | -52.0% |
| Q1 2020 | $8,515,000 | +18.1% | 1,008,897 | +22.4% | 0.02% | +56.2% |
| Q4 2019 | $7,210,000 | -21.0% | 823,958 | -2.8% | 0.02% | -27.3% |
| Q3 2019 | $9,124,000 | +40.8% | 847,590 | +66.2% | 0.02% | +37.5% |
| Q2 2019 | $6,482,000 | -87.1% | 510,000 | -60.7% | 0.02% | -87.2% |
| Q1 2019 | $50,340,000 | +61.8% | 1,297,759 | -15.1% | 0.12% | +47.1% |
| Q4 2018 | $31,113,000 | +655.7% | 1,528,900 | +1602.6% | 0.08% | +750.0% |
| Q3 2018 | $4,117,000 | -22.5% | 89,800 | 0.0% | 0.01% | -37.5% |
| Q2 2018 | $5,312,000 | -40.8% | 89,800 | -31.8% | 0.02% | -38.5% |
| Q1 2018 | $8,966,000 | +19.6% | 131,758 | +73.7% | 0.03% | +23.8% |
| Q4 2017 | $7,497,000 | +67.5% | 75,853 | +103.0% | 0.02% | +61.5% |
| Q3 2017 | $4,475,000 | +352.5% | 37,370 | +230.2% | 0.01% | +333.3% |
| Q2 2017 | $989,000 | -82.6% | 11,316 | -92.6% | 0.00% | -81.2% |
| Q1 2017 | $5,673,000 | +1358.4% | 152,500 | +1104.4% | 0.02% | +1500.0% |
| Q4 2016 | $389,000 | -58.4% | 12,662 | -9.3% | 0.00% | -66.7% |
| Q3 2016 | $936,000 | -37.3% | 13,965 | -72.1% | 0.00% | -25.0% |
| Q2 2016 | $1,494,000 | -95.2% | 50,139 | -62.1% | 0.00% | -95.8% |
| Q1 2015 | $31,260,000 | +3.6% | 132,393 | -16.9% | 0.10% | +2.2% |
| Q4 2014 | $30,170,000 | -57.7% | 159,400 | -46.7% | 0.09% | -59.4% |
| Q3 2014 | $71,307,000 | +132.0% | 298,892 | -35.8% | 0.23% | +138.5% |
| Q2 2014 | $30,730,000 | -37.3% | 465,600 | -1.1% | 0.10% | -41.5% |
| Q1 2014 | $49,029,000 | -2.2% | 470,800 | -2.7% | 0.16% | -5.2% |
| Q4 2013 | $50,119,000 | +96.3% | 484,100 | +1.7% | 0.17% | +76.5% |
| Q3 2013 | $25,536,000 | +13.5% | 475,900 | -6.1% | 0.10% | +10.1% |
| Q2 2013 | $22,499,000 | – | 507,085 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |